GlassScriptPhysician profile
David B Ensley
NPI 1912929266
$1,530.83
in general payments reported to CMS, 2019-2025
21 companies · $43.80 in 2025
The $43.80 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $95.86 · 2020: $218 · 2021: $571 · 2022: $240 · 2023: $97.81 · 2024: $265 · 2025: $43.80.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $406.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $406.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Therapeuticsmd, INC. | $351.17 | 2020-2022 | |
| Abbvie INC. | $345.56 | 2019-2021 | |
| Gynesonics, INC. | $135.93 | 2024 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Exeltis, USA INC. | $125.51 | 2019-2022 | |
| Agile Therapeutics, INC. | $101.20 | 2021-2023 | Twirla |
| Astellas Pharma US INC | $76.38 | 2023-2025 | Veozah, Myrbetriq |
| Coopersurgical, INC. | $72.04 | 2021-2024 | Sos |
| Pfizer INC. | $47.86 | 2023-2024 | |
| Evofem Biosciences, INC. | $41.17 | 2021 | |
| Dysis Medical, INC. | $32.57 | 2020-2022 | |
| Mylan Pharmaceuticals INC. | $23.06 | 2022 | |
| Mayne Pharma Commercial LLC | $22.77 | 2021 | |
| Smith+Nephew, INC. | $20.67 | 2024 | Pico, Renasys Touch, Acticoat 4" X 4" |
| Shield Therapeutics INC | $19.66 | 2024 | |
| Masimo Corporation | $19.65 | 2023 | Set and Rainbow Set |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Davol INC. | $18.51 | 2021 | |
| Roche Diagnostics Corporation | $17.29 | 2019 | |
| Medline Industries LP | $15.50 | 2023 | |
| Meditrina | $15.32 | 2022 | |
| Organon LLC | $15.01 | 2022 | |
| Myovant Sciences INC. | $14.00 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Ensley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.